Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Operating Margin (2019 - 2023)

Historic Operating Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 65000.0%.

  • Benitec Biopharma's Operating Margin changed N/A to 65000.0% in Q2 2023 from the same period last year, while for Mar 2024 it was 307028.57%, marking a year-over-year decrease of 2786918100.0%. This contributed to the annual value of 25441.33% for FY2023, which is 9838000.0% down from last year.
  • As of Q2 2023, Benitec Biopharma's Operating Margin stood at 65000.0%.
  • Benitec Biopharma's Operating Margin's 5-year high stood at 8248.57% during Q2 2020, with a 5-year trough of 379300.0% in Q1 2021.
  • Moreover, its 5-year median value for Operating Margin was 8038.89% (2023), whereas its average is 80620.4%.
  • As far as peak fluctuations go, Benitec Biopharma's Operating Margin plummeted by 2000000000bps in 2021, and later soared by 2000000000bps in 2022.
  • Over the past 5 years, Benitec Biopharma's Operating Margin (Quarter) stood at 2741.56% in 2019, then tumbled by -11787bps to 325900.0% in 2020, then skyrocketed by 94bps to 19340.0% in 2021, then tumbled by -107bps to 40071.43% in 2022, then tumbled by -62bps to 65000.0% in 2023.
  • Its Operating Margin stands at 65000.0% for Q2 2023, versus 8038.89% for Q1 2023 and 40071.43% for Q4 2022.